OrbiMed Advisors LLC's Form 4 filing
Repare Therapeutics Inc. (RPTX) · filed Sep 8, 2021
- Accession no.
- 0000947871-21-000986
- Filed
- Sep 8, 2021, 6:18 PM ET
- Trade date
- Sep 3-7, 2021
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $274.8K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | Director |
| OrbiMed Capital LLCCIK 0001157524 | Director |
| OrbiMed Capital GP VII LLCCIK 0001760648 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2021 | Common Stock | SSaleDisposed | −6,985 | $34.00 | −$237,490 | 3,177,902 | Indirect | Duplicate filing |
| Sep 3, 2021 | Common Stock | SSaleDisposed | −212 | $34.00 | −$7,208 | 96,216 | Indirect | Duplicate filing |
| Sep 7, 2021 | Common Stock | SSaleDisposed | −861 | $33.93 | −$29,213.73 | 3,177,041 | Indirect | Duplicate filing |
| Sep 7, 2021 | Common Stock | SSaleDisposed | −26 | $33.93 | −$882.18 | 96,190 | Indirect | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.